Aeris Biosciences raises $3.4M Seed (United States, Aug 2026)
Find the investors funding Health Seed rounds
326,000+ verified VCs, angels and family offices — direct emails, check sizes and stage filters.
Cleveland's Aeris Biosciences raises $3.4M seed to bring wound tech to humans - Dealroom
Aeris Biosciences is focused on developing innovative wound care technologies. The company aims to bring its advanced solutions to the human market, addressing significant needs in wound management. This funding round will support their efforts to commercialize their technology.
Cleveland's Aeris Biosciences raises $3.4M seed to bring wound tech to humans Dealroom
| Aug 31, 2026 | Easy Aerial | $20.0M | Series B | United States |
| Aug 31, 2026 | Blank Street | $105.0M | — | United States |
| Aug 31, 2026 | RQD Clearing | $74.0M | Minority Growth Investment | United States |
| Aug 31, 2026 | Corgi | $40.7M | — | United States |
20,048 investors back startups in United States
You just read who funded Aeris Biosciences. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 5 investor contact unlocks a month, no card required.